| |
HR (95% CI)†
|
p†
|
|---|
|
ABG level category*
|
Not adjusted to %LVEF
|
110–140 mg/dL
|
0.91 (0.75–1.10)
|
0.347
|
|
140–200 mg/dL
|
1.08 (0.90–1.29)
|
0.380
|
|
>200 mg/dL
|
1.20 (1.01–1.42)
|
0.032
|
|
Adjusted to %LVEF‡
|
110–140 mg/dL
|
1.05 (0.83–1.33)
|
0.665
|
|
140–200 mg/dL
|
1.20 (0.97–1.48)
|
0.091
|
|
>200 mg/dL
|
1.36 (1.12–1.66)
|
0.002
|
|
Per 18 mg/dL glucose (1 mmol/L)*
|
Not adjusted to %LVEF
|
1.02 (1.01–1.03)
|
<0.001
|
|
Adjusted to %LVEF‡
|
1.02 (1.01–1.04)
|
<0.001
|
|
Patients with ABG level < 200 mg/dL only
|
1.02 (0.98–1.06)
|
0.283
|
- To convert glucose to millimoles per liter, multiply by 0.055
-
ABG admission blood glucose, CI confidence interval, DM diabetes mellitus, HR hazard ratio, LVEF left ventricular ejection fraction
- * Adjusted for age, sex, COPD, NYHA 3,4, acute on chronic and chronic HF categories, statins, beta-blockers, furosemide, active malignancy, hemoglobin, urea, creatinine, SBP
-
†HR and p-value compared to ABG < 110 mg/dL
-
‡Of 3993 patients, 2775 had LVEF data
